|
|
Alpha Adrenergic Antagonist:
alfuzosin |
CONTRAINDICATED due to potential for serious reactions such as hypotension. |
Antiarrhythmics:
amiodarone, bepridil, flecainide, propafenone, quinidine |
CONTRAINDICATED due to potential for serious and/or life threatening reactions such as cardiac arrhythmias. |
Antifungal:
voriconazole |
CONTRAINDICATED due to significant decreases in voriconazole plasma concentrations and may lead to loss of antifungal response. |
Ergot Derivatives:
dihydroergotamine, ergonovine, ergotamine, methylergonovine |
CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by vasospasm and ischemia of the extremities and other tissues including the central nervous system. |
GI Motility Agent:
cisapride |
CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias. |
Herbal Products:
St. John's wort (hypericum perforatum) |
CONTRAINDICATED as the combination may lead to loss of virologic response and possible resistance to NORVIR or to the class of protease inhibitors. |
HMG-CoA Reductase Inhibitors:
lovastatin, simvastatin |
CONTRAINDICATED due to potential for serious
Manufacturer
Abbott Laboratories
Active Ingredients
Source
-
U.S. National Library of Medicine
-
DailyMed
-
Last Updated: 2nd of March 2011
|
|
